The report for Middle East and Africa Diabetes Market of Market Research Future comprises
extensive primary research along with the detailed analysis of qualitative as well as
quantitative aspects by various industry experts, key opinion leaders to gain the deeper
insight of the market and industry performance. On an average one in ten adult is suffering
from diabetes in Middle East and Africa region. Most of the case are of Type 2 diabetes and
it is growing rapidly. According to International Diabetes Federation Atlas, about 19.3% of
population between 20-79 age group is diabetic in UAE and the number is almost same in
Saudi Arabia, Qatar, Kuwait and Bahrain. These five nations has the highest rate of diabetes
per capita which is among the top 15 countries in the world. Increasing urbanization,
changing lifestyle and unhealthy eating habits are driving the growth for the market. Rising
middle class group, increasing per capita income, spending on healthcare and advanced
healthcare infrastructure facilities are driving the growth for the market in this region.
Middle East and Africa Diabetes Market is growing rapidly. Middle East and Africa Diabetes
Market is expected to grow at a CAGR of 5.1% and expected to reach US$ 16.4 billion by
2023 from US$ 11.6 billion in 2016.
Segments:
Middle East and Africa Diabetes Market has been segmented on the basis of type which
comprises Type 1, Type 2, and Gestational diabetes. On the basis of test, market is
segmented into Random blood sugar test, Fasting blood sugar test, Oral glucose tolerance
test, Initial glucose challenge test and others. On the basis of devices, it is segmented into
Blood glucose monitoring devices, Diabetes management devices, and others. On the basis
of treatment market is segmented into Medications, Insulin therapy, Transplantation,
Bariatric surgery and others.
Key Players for Middle East and Africa Diabetes Market:
Some of the key players in this market are: Abbott (US), Bayer AG (Germany), Becton
Dickinson and Company (US), Johnson & Johnson Services, Inc. (US), Merck & Co., Inc.
(US), Novartis AG (Switzerland), Novo Nordisk A/S (Denmark), Roche Diabetes Care, Inc.
(US), sanofi-aventis U.S. LLC (US), Ypsomed (Switzerland)
Get Sample Copy @ https://www.marketresearchfuture.com/sample_request/2971 .
Regional Analysis of Middle East and Africa Diabetes Market:
Considering the scenario of the Middle East and African diabetes market, Saudi Arabia is
believed to be the largest market for diabetes. Moreover the UAE also growing and second
largest market for Middle East and Africa Diabetes. On the other hand, Egypt market is
expected to grow at significant rate in the Middle East and Africa diabetes during the
forecasted period. Rest of Middle East and Africa is likely to have a limited but moderate
growth in the market.
The report gives the clear picture of current market scenario which includes historical and
projected market size in terms of value and volume, technological advancement, macro
economical and governing factors in the market. The report provides details information and
strategies of the top key players in the industry. The report also gives a broad study of the
different markets segments and regions.
…Continued
Apply for Discount @ https://www.marketresearchfuture.com/check-discount/2971 .
Top Reasons to Buy the Reports:
Company profiling with detailed strategies, financials, and recent development activities
Market Strategic Business Influence Data
Market Research Future recommendations in key business segments based on the
market estimations
Market share analysis of the top industry players
Market forecasts for a minimum of 5 years of all the mentioned segments, Trends and
the regional markets With SWOT Analysis
About Market Research Future: